IEM101, a naturally attenuated Vibrio cholerae strain as carrier for genetically detoxified derivatives of cholera toxin.

Keywords

Vibrio cholerae, Cholera toxin, Microbiology, Bacteria, Biology

References

• Actions of cholera toxin and the prevention and treatment of choleraE. D. Nakpodia — 1981
• ADP-ribosylation of guanyl nucleotide-binding regulatory proteins by bacterial toxins.Joel Moss, Martha Vaughan — 1988
• The comprehensive sourcebook of bacterial protein toxinsJoseph E. Alouf, Daniel Ladant, Michel R. Popoff — 1999
• Site-specific mutagenesis of the catalytic subunit of cholera toxin: substituting lysine for arginine 7 causes loss of activityW. Neal Burnette, V L Mar, B W Platler — 1991
• Importance of ADP-ribosylation in the morphological changes of PC12 cells induced by cholera toxinCorine Glineur, Camille Locht — 1994
• Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using a positive-selection suicide vectorMichael S. Donnenberg, James B. Kaper — 1991
• Tissue Receptor for Cholera Exotoxin: Postulated Structure from Studies with GM1 Ganglioside and Related GlycolipidsJan Holmgren, Ivar Lönnroth, Lars Svennerholm — 1973
• Synergistic protective effect in rabbits of immunization with Vibrio cholerae lipopolysaccharide and toxin/toxoidA M Svennerholm, Jan Holmgren — 1976
• A nontoxic mutant of cholera toxin elicits Th2-type responses for enhanced mucosal immunity.Shingo Yamamoto, Hiroshi Kiyono, Masafumi Yamamoto — 1997
• Safety, immunogenicity, and transmissibility of single-dose live oral cholera vaccine strain CVD 103-HgR in 24- to 59-month-old Indonesian children.C. H. Simanjuntak, P O’Hanley, Narain H. Punjabi — 1993
• Lysogenic Conversion by a Filamentous Phage Encoding Cholera ToxinMatthew K. Waldor, John J. Mekalanos — 1996
• An oral B subunit: whole cell vaccine against cholera.Jan Holmgren, Ann‐Mari Svennerholm, Marianne Jertborn — 1992
• ADP-ribosyl transferase activity of cholera toxin polypeptide A1 and the effect of limited trypsinolysis.Chun‐Yen Lai, Fiorella Descalzi Cancedda, Lawrence K. Duffy — 1981
• CTXphi immunity: application in the development of cholera vaccines.Harvey H. Kimsey, Matthew K. Waldor — 1998
• Cholera toxin genes: nucleotide sequence, deletion analysis and vaccine developmentJohn J. Mekalanos, Daryl J. Swartz, Gregory D. Pearson — 1983
• Construction of genetically marked Vibrio cholerae O1 vaccine strains.Julian M. Ketley, Jane M. Michalski, James E. Galen — 1993
• pEMBL: a new family of single stranded plasmids.Luciana Dente, Gianni Cesareni, Riccardo Cortese — 1983
• Crystal structure of a cholera toxin-related heat-labile enterotoxin from E. coliTitia K. Sixma, Sylvia E. Pronk, Kor H. Kalk — 1991
• Enterotoxicity of Bacteria-free Culture-filtrate of Vibrio choleraeS. N. De — 1959
• Positive transcriptional regulation of an iron-regulated virulence gene in Vibrio cholerae.Marcia B. Goldberg, S A Boyko, Stephen B. Calderwood — 1991

Cited by

• Construction and Evaluation of a Safe, Live, Oral Vibrio cholerae Vaccine Candidate, IEM108Daryl Siedentop — 2003
• Resistance of the cholera vaccine candidate IEM108 against CTXPhi infection.Guangwen Liu, Meiying Yan, Weili Liang — 2006
• The burden of choleraChandrika Murugaiah — 2011
• Use of stabilized luciferase-expressing plasmids to examine in vivo-induced promoters in the Vibrio cholerae vaccine strain CVD103-HgRCara E. Morin, James B. Kaper — 2009
• Mucosal vaccines: non toxic derivatives of LT and CT as mucosal adjuvants.Mariagrazia Pizza, Marzia Monica Giuliani, Maria Rita Fontana — 2001
• Investigation into immunological responses against a native recombinant CTB whole‐cell Vibrio cholerae vaccine in a rabbit modelMina Boustanshenas, Bita Bakhshi, Masoud Ghorbani — 2013
• Construction and characterization of an auxotrophic ctxA mutant of O139 Vibrio cholerae.Melissa Sue Ann Chan, Tan Gim Cheong, S. Kurunathan — 2010
• Construction and characterization of a thyA mutant derived from cholera vaccine candidate IEM101Fenggang Yu, Guoming Qi, Yanqing Liu — 2005
• Exploiting cholera vaccines as a versatile antigen delivery platformAnisia J. Silva, Francis O. Eko, Jorge A. Benítez — 2008
• The hows and whys of constructing a native recombinant cholera vaccineMina Boustanshenas, Bita Bakhshi — 2014
• The Use of Live Attenuated Bacteria as a Delivery System for Heterologous AntigensHelen S. Garmory, Sophie E.C. Leary, Kate F. Griffin — 2003
• A Single Point Mutation within the Coding Sequence of Cholera Toxin B Subunit Will Increase Its Expression YieldBita Bakhshi, Mina Boustanshenas, Masoud Ghorbani — 2014
• Comparison of a Regulated Delayed Antigen Synthesis System with In Vivo-Inducible Promoters for Antigen Delivery by Live Attenuated Salmonella VaccinesShifeng Wang, Yuhua Li, Huoying Shi — 2010
• Differential expression of receptors for Shiga and Cholera toxin is regulated by the cell cycle.Irina Majoul, Tobias Schmidt, Maria Pomasanova — 2002
• Mucosal delivery of anti-inflammatory IL-1Ra by sporulating recombinant bacteriaStefano Porzio, Paola Bossù, Paolo Ruggiero — 2004
• Immunoenhancing effects of a new probiotic strain, Lactobacillus fermentum PL9005.Jong‐Hwan Park, Jong‐Hwan Park, Yeon‐Hee Lee — 2005
• Sublingual Adjuvant Delivery by a Live Attenuated Vibrio cholerae-Based Antigen Presentation PlatformJulie Liao, J A Gibson, Bradley Pickering — 2018
• Chapter 56 – Antigen Delivery Systems II: Development of Live Recombinant Attenuated Bacterial Antigen and DNA Vaccine Delivery Vector VaccinesR. Curtiss — 2005
• Toxin-Based Mucosal AdjuvantsA. Harandi, N. Lycke — 2017
• Construction and Evaluation of a Safe , Live , Oral Vibrio cholerae Vaccine Candidate , IEM 108W. Liang, Shixia Wang, F. Yu — 2003

Related papers

• Cholera Due to Altered El Tor Strains of Vibrio cholerae O1 in BangladeshG. Balakrish Nair, Firdausi Qadri, Jan Holmgren — 2006
• Cholera Toxin Production by the El Tor Variant of Vibrio cholerae O1 Compared to Prototype El Tor and Classical BiotypesJayeeta Ghosh‐Banerjee, Mitsutoshi Senoh, Takuya Takahashi — 2010
• Inhibition of cholera toxin production by thiols in Vibrio choleraeTakahiro Shimamura, S Watanabe, S. Sasaki — 1986
• Cholera between 1991 and 1997 in Mexico Was Associated with Infection by Classical, El Tor, and El Tor Variants of Vibrio choleraeMunirul Alam, Suraia Nusrin, Atiqul Islam — 2010
• Proteomic Analysis of Vibrio cholerae in Human StoolRegina C. LaRocque, Bryan Krastins, Jason B. Harris — 2008
• Vibrio cholerae and cholera : molecular to global perspectivesKaye Wachsmuth, Paul A. Blake, Ørjan Olsvik — 1994
• CT− clinical isolates of Vibrio cholerae as potential oral vaccines for choleraUpasana Dasgupta, R K Bhadra, Dibyendu K. Panda — 1992
• Comparison of Vibrio cholerae O139 with V. cholerae O1 classical and El Tor biotypesKerstin E. Calia, M J Murtagh, Mary Jane Ferraro — 1994
• A Potential Epidemic Factor from the Bacteria, Vibrio cholerae WO7Shalmoli Bhattacharyya, Jasleen Shant, Nirmal Kumar Ganguly — 2007